Gene: CREB3L2
Official Full Name: cAMP responsive element binding protein 3 like 2provided by HGNC
Gene Summary: This gene encodes a member of the oasis bZIP transcription factor family. Members of this family can dimerize but form homodimers only. The encoded protein is a transcriptional activator. Translocations between this gene on chromosome 7 and the gene fused in sarcoma on chromosome 16 can be found in some tumors. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10388 | CREB3L2 Knockout cell line (HeLa) | Human | CREB3L2 | 1:3~1:6 | Negative | Online Inquiry |
KO10389 | CREB3L2 Knockout cell line (HCT 116) | Human | CREB3L2 | 1:2~1:4 | Negative | Online Inquiry |
KO10390 | CREB3L2 Knockout cell line (HEK293) | Human | CREB3L2 | 1:3~1:6 | Negative | Online Inquiry |
KO10391 | CREB3L2 Knockout cell line (A549) | Human | CREB3L2 | 1:3~1:4 | Negative | Online Inquiry |
CREB3L2 Gene Knockout Cell Lines are advanced biologically engineered cellular models that are specifically designed to study the functional role of the CREB3L2 gene, which encodes a transcription factor involved in various physiological processes, including stress response and cellular homeostasis. By utilizing CRISPR/Cas9 technology, these knockout cell lines demonstrate a remarkable ability to eliminate CREB3L2 expression, allowing researchers to investigate the downstream effects of its absence.
The primary function of these cell lines is to facilitate in-depth exploration of the CREB3L2 pathway. Researchers can examine alterations in gene expression profiles, protein interactions, and cellular responses to environmental stressors. The mechanisms underlying the CREB3L2-mediated transcriptional regulation can thus be elucidated, providing crucial insights into its roles in health and disease. This understanding is especially significant in the context of metabolic disorders, neurodegenerative diseases, and various cancers, where CREB3L2 may play an influential role.
In comparison to alternative models, CREB3L2 Gene Knockout Cell Lines offer unique advantages such as precise genetic modification, consistency in experimental conditions, and reduced variability often encountered in primary cell cultures. They serve as a reliable platform for drug discovery, pathophysiology studies, and therapeutic development, making them indispensable tools for both basic and translational research.
For researchers and clinicians alike, employing CREB3L2 Gene Knockout Cell Lines enables a nuanced approach to study gene function, enhancing the understanding of complex biological processes. The availability of these specialized tools equips scientists with the necessary resources to advance their research and contribute to significant scientific breakthroughs.
Our company, a leader in genetic engineering technologies, is committed to providing innovative biological products that empower the scientific community. With a focus on quality and reliability, our CREB3L2 Gene Knockout Cell Lines are an essential addition to any laboratory investigating gene function and its ramifications in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.